La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Charles River Laboratories International Gestion
Gestion contrôle des critères 4/4
Le PDG Charles River Laboratories International's est Jim Foster, nommé en Jan1991, a un mandat de 33.58 ans. La rémunération annuelle totale est $ 14.10M, composée du salaire de 10.4% et des bonus 89.6%, y compris les actions et options de la société. détient directement 0.46% des actions de la société, d'une valeur de $ 48.22M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.8 ans et 7.1 ans.
Informations clés
Jim Foster
Directeur général
US$14.1m
Rémunération totale
| Pourcentage du salaire du PDG | 10.4% |
| Durée du mandat du directeur général | 33.6yrs |
| Propriété du PDG | 0.5% |
| Durée moyenne d'occupation des postes de direction | 4.8yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.1yrs |
Mises à jour récentes de la gestion
Recent updates
US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10
Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
May 01Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?
Apr 16These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well
Apr 02Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?
Mar 19Charles River gains as Guggenheim upgrades despite post-earnings selloff
Feb 23Charles River Laboratories International: A Great Business At A Decent Price
Feb 06Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 29 2024 | n/a | n/a | US$432m |
| Mar 30 2024 | n/a | n/a | US$439m |
| Dec 30 2023 | n/a | n/a | US$475m |
| Sep 30 2023 | n/a | n/a | US$475m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$496m |
| Dec 31 2022 | US$13m | US$1m | US$486m |
| Sep 24 2022 | n/a | n/a | US$436m |
| Jun 25 2022 | n/a | n/a | US$443m |
| Mar 26 2022 | n/a | n/a | US$422m |
| Dec 25 2021 | US$14m | US$1m | US$391m |
| Sep 25 2021 | n/a | n/a | US$397m |
| Jun 26 2021 | n/a | n/a | US$396m |
| Mar 27 2021 | n/a | n/a | US$375m |
| Dec 26 2020 | US$13m | US$1m | US$364m |
| Sep 26 2020 | n/a | n/a | US$301m |
| Jun 27 2020 | n/a | n/a | US$271m |
| Mar 28 2020 | n/a | n/a | US$248m |
| Dec 28 2019 | US$18m | US$1m | US$252m |
| Sep 28 2019 | n/a | n/a | US$231m |
| Jun 29 2019 | n/a | n/a | US$219m |
| Mar 30 2019 | n/a | n/a | US$227m |
| Dec 29 2018 | US$14m | US$1m | US$225m |
| Sep 29 2018 | n/a | n/a | US$135m |
| Jun 30 2018 | n/a | n/a | US$128m |
| Mar 31 2018 | n/a | n/a | US$129m |
| Dec 30 2017 | US$13m | US$1m | US$123m |
Rémunération vs marché: La rémunération totale de Jim ($USD 14.10M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 13.21M ).
Rémunération et revenus: La rémunération de Jim a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Jim Foster (73 yo)
33.6yrs
Titularisation
US$14,096,923
Compensation
Mr. James C. Foster, J.D. has been the Chairman of the Board at Charles River Laboratories, Inc. (CRL) since 2000 and has been its Chief Executive Officer since 1992 and serves as its President since 1991....
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, President & Chairman | 33.6yrs | US$14.10m | 0.46% $ 48.5m | |
| Corporate Executive VP & CFO | 2.3yrs | US$3.81m | 0.0049% $ 518.3k | |
| Corporate Executive VP & COO | 2.8yrs | US$4.99m | 0.082% $ 8.7m | |
| Corporate Executive Vice President of Corporate Development & Strategy | 13.6yrs | US$3.06m | 0.021% $ 2.2m | |
| Corporate Executive Vice President of Community Relations | 7.8yrs | US$2.91m | 0.051% $ 5.4m | |
| Corporate Senior VP & Chief Accounting Officer | 7.3yrs | pas de données | 0.010% $ 1.1m | |
| Corporate Senior VP & Chief Scientific Officer | 2.8yrs | pas de données | pas de données | |
| Corporate Senior VP & Chief Information Officer | 3.2yrs | pas de données | pas de données | |
| Corporate Vice President of Investor Relations | no data | pas de données | pas de données | |
| Corporate Senior VP | 3.9yrs | pas de données | pas de données | |
| Corporate Vice President & Chief Communications Officer | no data | pas de données | pas de données | |
| Corporate Executive VP & Chief People Officer | 5.6yrs | pas de données | 0.020% $ 2.1m |
4.8yrs
Durée moyenne de l'emploi
54yo
Âge moyen
Gestion expérimentée: L'équipe de direction de CRL est considérée comme expérimentée (ancienneté moyenne 4.8 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, President & Chairman | 35.6yrs | US$14.10m | 0.46% $ 48.5m | |
| Independent Director | 13.6yrs | US$339.77k | 0.046% $ 4.8m | |
| Lead Independent Director | 21.6yrs | US$371.02k | 0.010% $ 1.1m | |
| Independent Director | 4.8yrs | US$346.02k | 0.0066% $ 699.5k | |
| Independent Director | 13.6yrs | US$346.02k | 0.062% $ 6.5m | |
| Independent Director | 1.7yrs | US$437.78k | 0.0018% $ 186.5k | |
| Director | 7.1yrs | US$336.02k | 0.022% $ 2.4m | |
| Independent Director | 15.8yrs | US$339.77k | 0.014% $ 1.5m | |
| Independent Director | 4.5yrs | US$339.77k | 0.0048% $ 504.5k | |
| Independent Director | 3.8yrs | US$324.77k | 0.0048% $ 509.8k | |
| Independent Director | less than a year | pas de données | 0.00033% $ 35.0k |
7.1yrs
Durée moyenne de l'emploi
68yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de CRL sont considérés comme expérimentés (ancienneté moyenne 7.1 ans).